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Studies in our laboratory have uncovered important distinctions concerning the
relative capacity of suckling as opposed to adult Lewis rats to develop experimental
allergic encephalomyelitis (EAE) as well as age-related differences in histopathologic
features of disease (1, 2). For example, EAE could not be induced in 10-day-old
suckling rats sensitized to rat myelin basic protein (RMBP) in complete Freund's
adjuvant (CFA) whereas sensitization of adult animals to RMBP-CFA induced
typical disease (1) . Whereas sensitization of suckling rats with guinea pig (GP) myelin
basic protein (MBP) or spinal cord did induce clinical neurological signs of EAE of
a transient nature which were accompanied by focal central nervous system (CNS)
lesions, these perivascular cellular infiltrates contained disproportionately large num-
bers of segmented neutrophils and occurred more often in white matter than was the
case in similarly sensitized adult animals (1, 2). Furthermore, appropriately sensitized
suckling rats were as effective as adult animals with respect to serving as donors of
lymph node cells for transfer of EAE to adult recipients (3). This observation, in
particular, suggested that the milieu of the immature rat diminishes expression of
effector cell activity.
It occurred to us that the reduced incidence and severity of EAE in suckling Lewis
rats might be due to a circulating MBP or MBP-like moiety of endogenous origin
capable of interacting with sensitized effector cells so as to reduce their capacity to
bind to CNS target MBP antigen and initiate injury. In support of this hypothesis,
we were able show that sera of normal suckling Lewis rats contained a factor which
additively inhibited primary binding of radiolabeled RMBP with syngeneic RMBP
reagent antibodies (4, 5). We concluded that the MBP serum factor, designated MBP-
SF, was immunochemically indistinguishable from native RMBP with respect to
immunodeterminants specific for reagent RMBP antibody (4) . It was of obvious
importance to determine the relationship between mean MBP-SF values and occur-
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rence of EAE in Lewis rats as functions of age. Our initial observations summarized
here suggest that MBP-SF has an important immunoregulatory influence on devel-
opment of EAE in rats sensitized to RMBP-CFA.
Materials and Methods
Animals.
￿
Adult male Lewis rats, 8-12-wk old, were obtained from Microbiological Associates
(Walkersville, Md.), Simonsen Laboratories, Inc. (Gilroy, Calif.) and Charles River Breeding
Laboratories, Inc. (Wilmington, Mass.). Suckling Lewis rats, by definition <28 days old, were
born and reared at Northwestern University or Duke University.
Antigen and Sensitization of Animals.
￿
RMBP obtained from Dr. Marian Kies, National
Institutes of Health, Bethesda, Md., was used for a single experiment. In all other experiments,
RMBP as well as GPMBP was prepared in our laboratory from syngeneic adult Lewis rats or
from random bred guinea pig spinal cord (purchased from Pel-Freeze Biologicals Inc., Roges,
Ark.), using the method of Deibler et al. (6) . Rats were injected with 50 lug RMBP or GPMBP
emulsified in CFA, distributed between each hindleg footpad as previously described (1) .
Serum and Plasma Specimens.
￿
Blood was collected by cardiac puncture from etherized rats.
Serum and plasma from several litters of sucklings (usually 8-12 animals per litter) and
individual adult rats were obtained as previously described (4). These frozen samples were
shipped over dry ice to Duke University and assayed for MBP-SF content. During the initial
phases of our work, these specimens were coded and ages of serum or plasma donor animals
divulged only after final bioassay results were recorded. Confirmatory data also were generated
by bioassay of specimens collected from Lewis suckling or adult rats at Duke University.
Radioimmunoassay (RIA) ofSamplesfor MBP-SF.
￿
The quantitative binding inhibition proce-
dure used throughout was as previously described (4) and employed 1251-RMBP as reagent
antigen and anti-RMBP raised in rabbits as reagent antibody. This procedure could detect
?0.6 ng of MBP eq/1AI.
Results
Mean values of MBP-SF in > 45 different serum and plasma pools and individual
serum specimens collected from normal Lewis rats of widely varying ages are shown
in Fig. 1 . Elevated levels of MBP-SF expressed as MBP-equivalents ranged from 5 to
8 ng/P,1 during the first 10 days after birth to peak concentrations usually exceeding
10 ng/A1 during the period 11-20 days old. Thereafter, MBP-SF levels gradually fell
to the barely detectable or undetectable levels found in rats 7 or more wk old, viz.,
<_ 6 ng/ftl.
A striking inverse relationship between MBP-SF levels and susceptibility to EAE,
in terms of incidence of histopathological changes with or without clinical signs of
disease after sensitization with RMBP-CFA, was observed among Lewis rats of
differing ages. This relationship is apparent in Fig. 2. With increasing age, mean
MBP-SF levels fell (as previously depicted in Fig. 1) whereas occurrence of EAE
increased to close to 100% incidence by 41-50 days of age. It should be stressed that
this inverse relationship (Fig. 2) holds only for rats 11 days or older. Rats much < 11
days old were found to be insusceptible to EAE due to limiting amounts of encepha-
litogenic antigen in their maturing CNS target tissue (1).
The relationship between MBP-SF levels and occurrence of EAE among suckling
and adult Lewis rats sensitized to a xenogeneic MBP, viz., GPMBP, is shown in Fig.
3. Because we had already noted the capacity of a moderate proportion of suckling
and virtually all adult Lewis rats to develop disease when sensitized to GPMBP-CFA
(1), it was not surprising to find no evident inverse relationship between MBP-SF
levels and occurrence of EAE in these animals.1718
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FIG . 1 .
￿
MBP-SF levels in normal Lewis rats ranging in age from <I day to 14 wk old, expressed
as means (t SEM) for age ranges indicated. Individual values ranged from < 0.6 ng/ltl (the
sensitivity of the RIA-inhibition procedure) to 21 .3 ng/Itl . El, MBP-SF.
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FIG . 2 .
￿
Mean MBP-SF levels of normal Lewis rats (as in Fig. 1) in relationship to occurrence of
EAE among animals sensitized to RMBP-CFA, for age ranges shower. O, MBP-SF; O, percent rats
withEAE.
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￿
Mean MBP-SF levels of normal Lewis rats (as shown in Fig. 1) in relationship to occurrence
ofEAE among animals sensitized to GPMBP-CFA, for age ranges shown . El, MBP-SF ; ®, percent
rats with EAE.
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Discussion
MBP-SF levels decrease progressively among suckling and weanling Lewis rats as
they mature (Fig. 1), whereas the occurrence of EAE, after sensitization with RMBP-
CFA, increases with age (Fig. 2) . This striking inverse relationship, we believe,
implicates MBP-SF as an endogenous immunoinhibitory neuroantigen acting to
suppress development of EAE among Lewis rats sensitized to syngeneic MBP. MBP-
SF may bear immunodeterminants other than those detected in our binding-inhibition
RIA (4, 5) specific for surface receptors on circulating effector lymphoid cells activated
by RMBP-CFA. By interacting with MBP-SF, such effector cells otherwise destined
to interact with autologous MBP in the host's CNS target may be desensitized and
rendered less injurious for MBP antigen in the CNS compartment. As a result of
diminished interaction ofeffector cells with target antigen, tissue injury translating to
EAE would be reduced or inhibited. Efforts are under way to demonstrate that
injections of pooled suckling rat serum containing high levels of MBP-SF have the
capacity to suppress EAE in adults sensitized to RMBP-CFA. We already have
reported that injections of pooled immune serum collected from adult rats after
recovery from EAE will suppress or completely inhibit disease in rats actively sensitized
to neuroantigen (7) .
The lack of relationship between MBP-SF levels and occurrence of EAE in rats
sensitized to a xenogeneic neuroantigen, i .e., GPMBP (Fig. 3), deserves comment in
view of the fact that most syngeneic antibodies raised against RMBP cross-react
extensively with MBP of guinea pig origin as well as MBP derived from many other
mammalian species (8) . Because the only MBP immunodeterminants detected by
RIA are those which elicit and/or bind to MBP antibody, and because other
laboratories (9-11) have provided evidence for other immunodeterminants specifically
engendering EAE activity and cell-mediated immunity, there are good reasons to
believe that endogenous RMBP-SF would not interact with EAE-receptor sites on
lymphocytes sensitized to GPMBP to a degree anticipated with lymphocytes sensitized
to syngeneic RMBP. Indeed, this could be one explanation for the well known greater
encephalitogenic activity of GPMBP, compared to RMBP, in both suckling and adult
Lewis rats (1, 2) .
Only trace amounts of MBP have been reported in fetal or postnatal maturing rat
CNS tissues until = 2 wk after birth, when substantial amounts of this myelinated
nerve protein begin to accumulate in nerve fibers together with cerebrosides and other
major components of myelin (12-14) . It is our premise that MBP probably is
synthesized within the CNS of very immature rats but its intercalation into maturing
myelin requires cerebrosides and other lipoproteins, which are not synthesized until
= 2 wk old. Soluble MBP of relatively low molecular weight, if not incorporated into
myelin, might well enter the systemic circulation. Shedding of endogenous neuroan-
tigen into the vascular compartment with distribution to peripheral lymphoid tissues
might be a means for early induction of immunologic tolerance to autologous MBP.
at least at the level of T cells, in agreement with the tenets of self tolerance developed
by Weigle and his associates (15) . There is every reason to believe that MBP-SF is
representative of the type of serum factor described by Cohen and his associates
(16-18) preventing sensitization of cultured lymphoid cells to syngeneic nervous tissue
and other auroantigens.1720
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Summary
Age-related concentrations of myelin basic protein serum factor (MBP-SF), an
endogenous neuroantigen detected and quantitated by inhibition of binding of rat
myelin basic protein (RMBP) antibody with 125I-RMBP reagent antigen and immu-
nochemically indistinguishable from native RMBP in this respect, reach peak levels
as high as 21 ng/jul among 2-3-wk-old normal suckling Lewis rats. Levels then
progressively decline to low, usually undetectable levels of < 0.6 ng/Itl MBP-equiva-
lents in adult animals by 7 wk of age. MBP-SF levels are inversely related to the age-
related increasing capacity of maturing Lewis rats to develop experimental allergic
encephalomyelitis (EAE) after sensitization to MBP ofsyngeneic, but not xenogeneic,
origin. MBP-SF appears to be an endogenous neuroimmunoregulatory product of
potential importance for immunologic tolerance to autologous RMBP in Lewis rats.
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